Send the following on WhatsApp
Continue to ChatDHPC from Novartis: Updated recommendations to minimize the known risk of intraocular inflammation, including retinal vasculitis and/or retinal vascular occlusion https://publicsafetyandvigilance.com/2021/11/1-updated-recommendations-to-minimize-the-known-risk-of-intraocular-inflammation-including-retinal-vasculitis-and-or-retinal-vascular-occlusion-dhpc-from-novartis/